Clinical Pharmacist & Fellowship Director
Aegis Sciences Corporation
Nashville, Tennessee
Dr. Andrew Holt received his Doctor of Pharmacy degree from the University of Tennessee Health Science Center and is licensed to practice in multiple states. Prior to joining Aegis, Dr. Holt worked for the Tennessee Board of Pharmacy as Executive Director and was Director of Tennessee’s Prescription Drug Monitoring Program. He holds additional certifications in medical affairs, pharmacogenomics, and drugs in sport. Dr. Holt is an assistant professor for the Department of Clinical Pharmacy and Translational Science at the University of Tennessee College of Pharmacy, serves as a preceptor for six colleges of pharmacy and is a co-Director of the post-doctoral Fellowship Program, a collaboration with Belmont College of Pharmacy. One of his primary interests is the surveillance and detection of novel psychoactive substances and their role in overdoses.
TP3 - Use of Novel Psychoactive Substances Among Individuals Prescribed Buprenorphine
Tuesday, April 16, 2024
12:45 PM – 1:15 PM CT